Takeda Launches LaunchesHemophilia Drug Adynovate InIndia

Adynovate Is An Extended Half-Life Recombinant Factor Viii (Rfviii) Treatment, Using Established Technology (Controlled Pegylation), For Hemophilia A Patients. This Option Offers Lower Weekly Infusion Rates Than Standard Fviii, Providing Excellent Prophylactic Coverage. Takeda Pharma Has Expanded Its Innovative Rare Diseases Portfolio In India With The Launch Of Adynovate, An Innovative Extended Half-Life Recombinant Factor Viii (Rfviii) Treatment, Using Established Technology (Controlled Pegylation), For Haemophilia A Patients, A Company Statement Said. It Also Said That Adynovate, In Combination With Mypkfit, The First And Only Fdaapproved Application, Offers Personalised And Interactive Prophylaxis Treatment Option That Enables Both Healthcare Professionals And Patients In Real-Time Monitoring Of Factor Viii Levels From The Comfort Of Their Homes On Phone Thereby Adapting Their Activity Decisions Accordingly And Help Improve Their Quality Of Life. Alerts Are Sent To Patients On Prophylaxis When Their Estimated Factor Viii Levels Are Low, And Reminds Them When Their Infusions Are Due, Thereby Providing Excellent Prophylactic Coverage. Administered In Three Steps With The Baxject Iii System, Adynovate Eliminates The Need To Disinfect The Vial, As Vials Are Already Assembled In The System Housing. It Can Be Stored At Room Temperature Not To Exceed 30

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!